- Home
- FTV vs HOLX Comparison
FTV vs HOLX Comparison
Compare FTV & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTV | HOLX |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | 18000 | N/A |
| Industry | Industrial Machinery/Components | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8B | 16.6B |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FTV | HOLX |
|---|---|---|
| Price | $53.92 | $75.68 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 13 |
| Target Price | $60.00 | ★ $77.89 |
| AVG Volume (30 Days) | ★ 3.0M | 2.9M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.44% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.73 | 0.79 |
| Revenue | ★ $6,452,700,000.00 | $4,100,500,000.00 |
| Revenue This Year | $4.73 | $4.74 |
| Revenue Next Year | $3.95 | $5.03 |
| P/E Ratio | ★ $31.64 | $95.76 |
| Revenue Growth | ★ 12.10 | 1.74 |
| 52 Week Low | $46.34 | $51.90 |
| 52 Week High | $74.52 | $75.75 |
Technical Indicators
Market Signals| Indicator | FTV | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 39.17 | 59.45 |
| Support Level | $52.82 | $75.10 |
| Resistance Level | $55.98 | N/A |
| Average True Range (ATR) | 1.42 | 0.21 |
| MACD | -0.16 | 0.02 |
| Stochastic Oscillator | 10.28 | 84.67 |
Price Performance
Historical ComparisonAbout FTV Fortive Corporation
Fortive is a diversified industrial technology firm with a broad portfolio of mission-critical products and services that include field solutions, product realization, health, and sensing technologies. The company serves a wide range of end markets, including manufacturing, utilities, medical, and electronics. Fortive generated roughly $6.2 billion in revenue in 2024.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.